MedTrace Logo

Outcomes of Patient Blood Management in Severely Anemic Patients

NCT06345417 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2024-04-03

No results posted yet for this study

Summary

The goal of this observational cohort study is to compare patients with very low red blood counts who receive different therapy. Its main question\[s\] it aims to answer are:

* Which group of patients dies more frequent: Patients who receive patient blood management only, patients who receive patient blood management and transfusions or patients who receive only transfusions?
* Among these groups: which group of patients has more complications during hospital stay? Patients will either receive patient blood management, which is the management of anemia, bleeding and coagulation problems, will receive transfusions, that is, blood from other people, or a mix of both.

Conditions

  • Severe Anemia

Interventions

OTHER

Patient Blood Management (PBM)

PBM is a strategy to manage the participant's own blood. Its focus is on anemia, bleeding and coagulation management.

BIOLOGICAL

Allogeneic transfusion

Anemia is treated by administering donor red cells, and bleeding or coagulopathy by plasma, platelets or other donor blood products.

Sponsors & Collaborators

  • HELIOS Hospital, Erfurt, Germany

    collaborator OTHER

  • Helios Klinik Gotha/Ohrdruf

    lead OTHER

Principal Investigators

  • Petra Seeber · HELIOS Klinikum Gotha

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2025-04-01
Completion
2025-05-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06345417 on ClinicalTrials.gov